Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_assertion type Assertion NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_head.
- NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_assertion description "[Given that sPLA2-IIa overexpression is associated with prostate development and progression, serum sPLA2-IIa may serve as a prognostic biomarker for prostate cancer and a potential surrogate prostate biomarker indicative of tumor burden.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_provenance.
- NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_assertion evidence source_evidence_literature NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_provenance.
- NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_assertion SIO_000772 20837598 NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_provenance.
- NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_assertion wasDerivedFrom befree-20150227 NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_provenance.
- NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_assertion wasGeneratedBy ECO_0000203 NP795563.RAzbDujQScaGgrWT9oKD4ooyUF5IAUNZeK_JF14Ap6xkE130_provenance.